Contributor Page
Ropes & Gray LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
New York
NY 10036-8704
United States
Awards
By Ruchit Patel
EU and UK antitrust laws make it illegal for dominant firms to charge unfair or excessive prices.
By John Chesley
John Chesley, Ropes & Gray health care partner, addresses developments for providers to consider as they join together and move towards value-based health care models.
By Ropes & Gray LLP's Investment Management Practice Group
The following summarizes recent legal developments of note affecting the mutual fund/investment management industry:
By Mark Barnes, Gregory Levine, Abram Barth, David Peloquin
On July 25, 2017, the U.S. Food and Drug Administration issued a guidance document1 announcing its intention not to object to an institutional review board's (IRB) waiving or altering of the informed consent requirements for an FDA-regulated clinical investigation that presents no more than minimal risk and involves adequate human subjects protections.
By Deborah Monson, Jeremy A. Liabo, Lindsey K. Jones
Just days before a new notice filing requirement for certain position limit aggregation exemptions was to take effect, on August 10, 2017 the staff of the U.S. Commodity Futures Trading Commission...
By James DeGraw
Jim DeGraw, Ropes & Gray technology partner, addresses cloud computing security issues that companies should be aware of as they consider moving data to the cloud.
By Ropes & Gray LLP's Mergers & Acquisitions Practice
In DFC Global Corp. v. Muirfield Value Partners, L.P.,1 the Delaware Supreme Court reversed and remanded the Court of Chancery's appraisal decision relating to the 2014 acquisition of DFC Global Corporation, an international non-bank provider of alternative financial services (a "payday lender"), by a private equity buyer, Lone Star.
By Peter Rosenberg, William Jewett, Sabrina Glaser, Joshua Lichtenstein
On August 9, 2017, the U.S. Department of Labor (the "DOL") filed a notice in connection with pending litigation that revealed a portion of its current plans for the fiduciary rule.
By Rohan Massey
The European Parliament's Civil Liberties, Justice and Home Affairs Committee visited Washington in the last week of July, not for a summer holiday, but to discuss the upcoming Privacy Shield review...
By Nicholas Berg, Michael Littenberg, David Nordsieck
A recent trio of cases filed in California state court seek to hold major fossil fuel companies liable for the effects of sea level rise they allege to be caused by climate change.
By Mark Barnes, Gregory Levine, Abram Barth
As part of an overarching initiative to update its regulatory oversight of digital health technologies, the U.S. Food and Drug Administration has announced new plans to streamline the development...
By Ropes & Gray LLP's FDA Regulatory Practice
On July 12, 2017, the House of Representatives passed H.R. 2430, the FDA Reauthorization Act of 2017, and on August 3, 2017, the Senate followed suit by passing FDARA without amendment by a vote of 94-1.
By Ryan Rohlfsen, Dante Roldan, Sarah M. Kimmer
The DOJ secured an important victory for its FCPA enforcement efforts on July 27, 2017, when a Manhattan jury found Chinese billionaire Ng Lap Seng guilty on six counts related to a bribery scheme.
By Matthew Rizzolo
The TPNTPA focuses on the U.S. International Trade Commission (ITC), a quasi-judicial federal agency in Washington, D.C. with broad investigative powers on matters of trade
By Heather Egan Sussman, Douglas Meal, James DeGraw, Seth Harrington, Mark Szpak, Michelle Visser, Deborah Gersh, Paul Rubin, Marc Berger, David Cohen, Nicole Gelsomini
On July 17, FTC Acting Chairman Maureen Ohlhausen announced a set of process reforms within the agency's Bureau of Consumer Protection aimed at streamlining information requests...
Contributor's Topics
More...